Aroa Biosurgery LtdASX: ARX

AROA Appoints Mark Dunwoodie as CFO

· Issued by Aroa Biosurgery Ltd via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Aroa Biosurgery Ltd has announced the appointment of Mark Dunwoodie as Chief Financial Officer and Joint Company Secretary, effective mid-November. This appointment supports a smooth transition from the outgoing CFO, James Agnew, who will leave the company at the end of November. CEO Brian Ward expressed confidence in Dunwoodie's ability to contribute to Aroa's growth strategy, particularly in the United States.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX ANNOUNCEMENT 3 November 2026 A R O A A P P O I N T S M A R K D U N W O O D I E A S C H I E F F I N A N C I A L O F F I C E R Highlights ? Mark Dunwoodie appointed Chief Financial Officer and Joint Company Secretary, effective 16 November 2026. ? More than 25 years of financial, strategic, and...

Aroa Biosurgery Ltd on 6ix

Earlier from Aroa Biosurgery

Later from Aroa Biosurgery

All Aroa Biosurgery news releases